Tag: Switzerland

ObsEva Files Second Quarter 2022 Financial Statements

By DKODING Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – August 17, 2022 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today published its Second Quarter 2022 Financial Statements. The Second […]

Finalization of Vifor Pharma acquisition

By DKODING Business Wire India All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead the business as General Manager upon settlement of the offer Regulatory News:   This press release features multimedia. View the full […]